- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
ANG Lifesciences India Ltd manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vialsBusiness Overview: Company manufactures and sells products like injections, tablets, capsules, syrups, ointments of different varieties. It deals in 4 market segments: institutional segment, third party manufacturing, direct marketing and export...
ANG Lifesciences has submitted a certificate from its Registrar and Share Transfer Agent, confirming the diligent processing of shareholder requests to convert physical shares into electronic form. The company’s RTA confirmed that all securities received for dematerialization were properly processed and listed on the stock exchange. Furthermore, physical share certificates...
The company has announced the closure of its trading window for insiders, designated persons, and their immediate relatives, effective from July 1, 2026. This closure will remain in effect until 48 hours after the declaration of the standalone and consolidated financial results for the quarter ended June 30, 2026. This...
&b CIN No:- L24230PB2006PLC030341 Aflg& GST No:- 02AAHCA5390H2ZT ANG LIFESCIENCES ' " INDIALIMITED Ref. No. .aum]..zs'fl] 21 Date. 05-0472026... To Department of Corporate Affairs ¢ BSE Limited P.). Towers, Dalal Street Mumbai -400001 Ref: Script code - 540694 Sub: Disclosure under Regulation 30 and 47 of the SEBI (Listing Obligations...